PhysiCell-X

Implementation of MPI in PhysiCell code

Institution:

Research Group:

BSC Group: Computational Biology - Life Sciences

Researcher/s:

Miguel Ponce de Leon, Arnau Montagud, Gaurav Saxena, Jose Estragués, Thaleia Ntiniakou, Jose Carbonell-Caballero, Alfonso Valencia, David Vicente

Description:

PhysiCell-X adds MPI domain-decomposition to the open-source agent-based simulator PhysiCell and PhysiBoSS, letting tissue-scale cancer or infection models spill across many HPC nodes. That delivers the speed and scale required for patient-specific “digital-twin” therapy treatment simulations.

PhysiCell-X is a high-potential engine for patient-specific digital-twin modelling. By adding distributed CPU kernels, it could become an indispensable decision-support layer for adaptive oncology and complex-tissue pharmacology.

Value Proposition:

Run a full-tumour virtual trials

Aplication areas:

Drug treatment, drug repurposing, virtual clinical trials, digital twins

Target market:

Pharmaceutical; Software as a medical device

Technology Readiness Level (1-9): 4

Protection:

BSD License (Version 3.0)

More information

if you want to know more about this project do not hesitate to contact us